A Study of the Effectiveness of Cabozantinib in Combination With Nivolumab as First-line Treatment of Advanced Renal Cell Carcinoma (aRCC) in Adults

Active, not recruitingOBSERVATIONAL
Enrollment

311

Participants

Timeline

Start Date

September 26, 2022

Primary Completion Date

May 31, 2026

Study Completion Date

November 30, 2026

Conditions
Advanced Renal Cell Carcinoma
Trial Locations (66)

Unknown

CHU St Pierre & Brugmann, Brussels

Jessa Ziekenhuis, Hasselt

CHU Namur Mont-Godinne, Yvoir

Centre Hospitalier Universitaire (CHU) de Angers, Angers

Hopital de Mercy- CHR Metz Thionville, Ars-Laquenexy

Institut Ste Catherine - Institut du Cancer Avignon Provence, Avignon

Centre Hospitalier Régional Universitaire de Besançon - Jean Minjoz, Besançon

ICONE, Bezannes

Groupe Hospitalier Saint-André (Bordeaux), Bordeaux

Institut Bergonié, Bordeaux

Centre Hospitalier de Boulogne-sur-mer, Boulogne-sur-Mer

Centre Hospitalier Fleyriat, Bourg-en-Bresse

Centre Finisterien de Radiotherapie et d'Oncologie, Brest

Centre d'Urologie Site Médipole - Centre Catalan d'Urologie, Cabestany

Centre de Lutte Contre le Cancer Jean PERRIN, Clermont-Ferrand

Centre Hospitalier Universitaire de Clermont-Ferrand - Gabriel-Montpied, Clermont-Ferrand

Centre Hospitalier Universitaire (CHU) Henri Mondor, Créteil

Centre Georges François Leclerc, Dijon

Institut de Cancérologie de Bourgogne, Dijon

Centre Hospitalier Annecy Genevois, Épagny

Centre Hospitalier intercommunal Saint Raphaël Frejus, Fréjus

Centre Hospitalier Départemental Vendée, La Roche-sur-Yon

Groupe Hospitalier De La Rochelle - Ré - Aunis, La Rochelle

Centre Hospitalier Universitaire Grenoble Alpes, La Tronche

Hôpital Privé Le Bois, Lille

Hopital Privé Jean Mermoz, Lyon

Centre Hospitalier Universitaire (CHU) de Nantes - Hôtel-Dieu, Nantes

Centre Hospitalier Régional D'orléans, Orléans

Centre Hospitalier Tenon, Paris

Hopital Bichat -Claud Bernard, Paris

Hôpital Européen Georges Pompidou (HEGP), Paris

Hôpital Pitié-Salpétrière, Paris

Centre Hospitalier Universitaire (CHU) de Poitiers, Poitiers

CHU Charles Nicolle, Rouen

Clinique Mathilde Oncologie médicale, Rouen

Centre d'Oncologie de l'Estuaire, Saint-Nazaire

ICANS - Institut de cancérologie Strasbourg Europe, Strasbourg

Hospital Foch - Oncology Service, Suresnes

Hospital Foch - Urology Service, Suresnes

Centre Hospitalier Régional Universitaire de (CHRU) de Tours - Hôpital Bretonneau, Tours

CH Dentellières, Valenciennes

Institut de Cancérologie de Lorraine Alexis Vautrin, Vandœuvre-lès-Nancy

General Hospital of Athens Alexandra, Athens

Henry Dunant Hospital, Athens

ATTIKO University Hospital, Chaïdári

Papageorgiou General Hosp of Thessaloniki, Thessaloniki

Ospedale Generale Provincial, Macerata

"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, IRCCS - Oncologia", Meldola

Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan

"Istituto Nazionale Tumori IRCCS Fondazione G. Pascale", Napoli

AOU San Luigi Gonzaga, Orbassano

IOV - Istituto Oncologico Veneto - IRCCS - Ospedale Busonera, Padua

P.O Santa Maria delle Grazie, ASL Napoli 2 Nord, Pozzuoli

"Ospedale Santa Maria delle Croci di Ravenna", Ravenna

Ospedale San Camillo Forlanini, Roma

Policlinico Universitario Campus Biomedico, Roma

PU A.Gemelli, Università Cattolica del Sacro Cuore, Roma

Akershus Universitetssykehus, Lørenskog

King Abdulaziz Medical City - Jeddah, Jeddah

King Abdulaziz Medical City- Riyadh, Riyadh

Chonnam National University Hwasun Hospital, Jeongnam

Samsung Medical Center, Seoul

Seoul St Mary's Hospital, Seoul

Severance Hospital, Yonsei University Health System, Seoul

Belfast City Hospital, Belfast

Edinburgh Cancer Centre, Western General Hospital, Edinburgh

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Ipsen

INDUSTRY